(CARE) Careium - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0017131824

CARE: Alarms, Sensors, Fall Detection, GPS Tracking, Monitoring

Careium AB is a technology-driven care services provider operating across multiple European countries, including Sweden, Norway, the UK, the Netherlands, Germany, France, and Spain. The company offers a comprehensive range of innovative solutions, including social alarms, sensors, cameras, and monitoring services, designed to enhance the safety and well-being of individuals, particularly the elderly and those with special needs.

The companys product portfolio is diverse and includes Visit, a virtual monitoring service that replaces physical home visits, as well as various devices such as mBox9200, Motion9200, Enzo, and PikoButton, which cater to different user requirements. Additionally, Careiums solutions, such as Abby, a mobile GPS social alarm, and Eliza S, a welfare hub, provide enhanced security and reliability for users, alarm receiving centers, and service providers. The companys i-care plus mobile application and monitoring centers further complement its offerings.

With a history dating back to 1974, Careium has established itself as a veteran player in the care services industry. Its headquarters is located in Malmö, Sweden, and it is listed on the stock exchange with the ticker symbol CARE. As a common stock, it is classified under the GICS Sub Industry: Security & Alarm Services.

Analyzing the available and , we can observe that the stock has experienced a decline in recent times, with the last price at 27.70 SEK, below its SMA20, SMA50, and SMA200. The ATR indicates a relatively moderate volatility. Considering the P/E ratio of 11.42 and RoE of 7.92, the stock appears to be undervalued. Based on these inputs, a forecast suggests that if the company can maintain its current growth trajectory and improve its profitability, the stock price may experience an upward correction, potentially targeting the 52W High of 36.60 SEK. However, this would require a significant improvement in the companys financials and market sentiment.

To achieve this, Careium needs to focus on expanding its customer base, enhancing its product offerings, and improving operational efficiency. If successful, this could lead to increased revenue growth, improved profitability, and a re-rating of the stock. A potential target price could be around 35-40 SEK in the next 12-18 months, representing a 25-45% upside from current levels. However, this is contingent upon the companys ability to execute its strategy and adapt to changing market conditions.

Additional Sources for CARE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CARE Stock Overview

Market Cap in USD 69m
Sector Industrials
Industry Security & Protection Services
GiC Sub-Industry Security & Alarm Services
IPO / Inception

CARE Stock Ratings

Growth Rating -0.46
Fundamental 54.8
Dividend Rating 0.0
Rel. Strength -19.1
Analysts -
Fair Price Momentum 23.03 SEK
Fair Price DCF 20.90 SEK

CARE Dividends

No Dividends Paid

CARE Growth Ratios

Growth Correlation 3m -73.3%
Growth Correlation 12m -34.3%
Growth Correlation 5y 68.4%
CAGR 5y -4.53%
CAGR/Max DD 5y -0.06
Sharpe Ratio 12m -0.11
Alpha -15.64
Beta 0.436
Volatility 40.19%
Current Volume 70.5k
Average Volume 20d 18.6k
What is the price of CARE stocks?
As of May 12, 2025, the stock is trading at SEK 27.40 with a total of 70,502 shares traded.
Over the past week, the price has changed by -1.08%, over one month by -2.49%, over three months by -8.67% and over the past year by -10.75%.
Is Careium a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Careium (ST:CARE) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.82 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CARE as of May 2025 is 23.03. This means that CARE is currently overvalued and has a potential downside of -15.95%.
Is CARE a buy, sell or hold?
Careium has no consensus analysts rating.
What are the forecast for CARE stock price target?
According to ValueRays Forecast Model, CARE Careium will be worth about 25 in May 2026. The stock is currently trading at 27.40. This means that the stock has a potential downside of -8.65%.
Issuer Forecast Upside
Wallstreet Target Price 30.5 11.3%
Analysts Target Price - -
ValueRay Target Price 25 -8.6%